Christopher Strouse

Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant

Christopher Strouse, Ying Zhang, Mei‐Jie Zhang et al. · Biology of Blood and Marrow Transplantation · 2018 · 75 citations · Full text

Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience

Danai Dima, James A. Davis, Nausheen Ahmed et al. · Transplantation and Cellular Therapy · 2023 · 68 citations

Hematological Malignancy, Oncology, Real-world Experience +6

The cohesin subunit Rad21 is a negative regulator of hematopoietic self-renewal through epigenetic repression of Hoxa7 and Hoxa9

Joseph B. Fisher, Jonathan Peterson, Michael Reimer et al. · Leukemia · 2016 · 64 citations · Full text

Chromatin, Hematopoietic Self-renewal, Developmental Biology +15

Defibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the Center for International Blood and Marrow Transplant Research

Christopher Strouse, Paul G. Richardson, Grant Prentice et al. · Biology of Blood and Marrow Transplantation · 2016 · 60 citations · Full text

Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study

Carla Casulo, Melissa C. Larson, Julianne J. Lunde et al. · The Lancet Haematology · 2022 · 60 citations · Full text

Lymphoid Neoplasia, Oncology, Systemic Treatment +5